Hilarity ensues… Laughter is the best medicine, that’s what they say, isn’t it? It’s not a universal truth, sometimes ...

The Chicago-based biopharma is growing its specialty portfolio through a licensing agreement for a novel antibiotic approved ...

Meitheal Pharmaceuticals has gained exclusive US commercial rights for a first-in-class semi-synthetic pleuromutilin ...

As the problem of antibiotic resistance continues to grow, we need new drugs that the bad bacteria in our bodies don't ...

MISSISSAUGA, Ontario and MANCHESTER, United Kingdom, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, ...

Alumnus Margie Lee, who transformed poultry health research and broke barriers in veterinary medicine, will be the keynote ...

The development of an indigenous antibiotic Nafithromycin is an important achievement by Indian scientists, and may be ...

The development of an indigenous antibiotic Nafithromycin is an important achievement by Indian scientists, and may be ...

India is among the countries hardest hit by "antimicrobial resistance". In 2019 alone, antibiotic-resistant infections caused ...

Long-term antibiotic exposure may be linked to a higher risk for rheumatoid arthritis (RA), according to study results published in Rheumatology.

It is a historic medical breakthrough as the first new antibiotic in its class to be developed globally in over 30 years. “This development is crucial as pneumonia remains one of the leading causes of ...

SYDNEY, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q), the Company developing a new class of synthetic anti-infectives, today announced the Australian Patent Office ...